F.D.A. to weigh over-the-counter sale of contraceptive pills

Kelly Blanchard, president of Ibis Reproductive Health (which operates Free the Pill), was interviewed for this article in The New York Times.

Previous
Previous

Why over-the-counter birth control has taken so long in the US

Next
Next

FDA weighs first-ever application for over-the-counter birth control pills in the wake of Roe’s fall